12 January 2024

Hogan Lovells advises Omega Therapeutics on research collaboration transaction with Novo Nordisk and Flagship Pioneering

Advising firms

5 lawyers named

Lawyer	Firm	Seniority	Practice	Office
Cullen Taylor Lead	Hogan Lovells Cadwalader	Partner	Not stated	Northern Virginia
Stephen Nicolai Lead	Hogan Lovells Cadwalader	Partner	Not stated	Philadelphia
Melissa Schwaller	Hogan Lovells Cadwalader	Senior associate	Not stated	Houston
Daniel Davidson	Hogan Lovells Cadwalader	Counsel	Not stated	Washington, D.C.
Estefania McCarroll	Hogan Lovells Cadwalader	Associate	Not stated	Northern Virginia

2 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.

Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.

Stated value: Not stated
What the figure measures: Not stated
Client: Omega Therapeutics, Inc.Joint venture party
Counterparties: Novo Nordisk (Joint venture party)
Flagship Pioneering (Joint venture party)